Pharma Companies Urge Reduced Barriers To Access Ahead Of UN Meeting On Non-communicable Disease In Developing Countries
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The growing incidence of non-communicable diseases is driving health authorities, non-governmental organizations and pharmaceutical companies to shift priorities. In September, the United Nations plans to hold a high level meeting on NCDs to address "prevention and control," particularly in developing countries
You may also be interested in...
Ahead Of UN Meeting, Stakeholders Urged To Embrace Fight Against NCDs - IFPMA Report
HONG KONG - Large discrepancies in wealth, weak access to healthcare and poor distribution networks are among the key challenges developing nations face in tackling the growing threat of non-communicable diseases
Ahead Of UN Meeting, Stakeholders Urged To Embrace Fight Against NCDs - IFPMA Report
HONG KONG - Large discrepancies in wealth, weak access to healthcare and poor distribution networks are among the key challenges developing nations face in tackling the growing threat of non-communicable diseases
Can Milestone-based Prizes Spur Development Of Global Health Solutions?
HONG KONG - A team from BIO Ventures for Global Health (BVGH) is in Washington, DC, this week seeking support for a proposed milestone-based prize to stimulate R&D for point-of-care fever diagnostics